| RS1598381121 |
STAT3
|
Health Risk |
Likely pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS1598381169 |
STAT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inherited Immunodeficiency Diseases, STAT3 gain of function |
| RS1598381778 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1598383011 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1598393453 |
STAT3
|
Health Risk |
Likely pathogenic |
— |
| RS1598394988 |
TMEM94
|
Health Risk |
Pathogenic |
— |
| RS1598399795 |
STAT3
|
Health Risk |
Pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS1598405334 |
SCN4A
|
Health Risk |
Pathogenic |
Hyperkalemic periodic paralysis, SCN4A-related disorder |
| RS1598406623 |
STAT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS1598406651 |
STAT3
|
Health Risk |
Likely pathogenic |
— |
| RS1598406692 |
SCN4A
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 16, Congenital myasthenic syndrome 16 |
| RS1598408073 |
MAPT
|
Health Risk |
Pathogenic/Likely pathogenic |
Frontotemporal dementia, Frontotemporal dementia |
| RS1598408336 |
MAPT
|
Health Risk |
Pathogenic |
Frontotemporal dementia, Frontotemporal dementia |
| RS1598411105 |
RPGRIP1L
|
Health Risk |
Likely pathogenic |
— |
| RS1598413522 |
PPM1D
|
Health Risk |
Likely pathogenic |
— |
| RS1598413570 |
PPM1D
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold, Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold |
| RS1598415635 |
STAT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inherited Immunodeficiency Diseases, STAT3 gain of function |
| RS1598416221 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS1598423756 |
STAT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS1598426626 |
SMCHD1
|
Health Risk |
Likely pathogenic |
Scapulohumeral muscular dystrophy, Scapulohumeral muscular dystrophy |
| RS1598429555 |
GNAL
|
Health Risk |
Likely pathogenic |
Limb dystonia, Dysarthria |
| RS1598431052 |
PIEZO2
|
Health Risk |
Pathogenic |
Arthrogryposis, distal |
| RS1598432041 |
TLK2
|
Health Risk |
Likely pathogenic |
— |
| RS1598441446 |
KANSL1
|
Health Risk |
Pathogenic |
— |
| RS1598448639 |
RAD51C
|
Health Risk |
Likely pathogenic |
— |
| RS1598448876 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1598448896 |
RAD51C
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group O, Breast-ovarian cancer |
| RS1598449381 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1598449660 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1598455555 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1598455598 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1598456075 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1598456274 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1598459949 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1598460116 |
RAD51C
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1598460178 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1598460593 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1598460710 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1598460753 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1598460983 |
RAD51C
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1598467175 |
RAD51C
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1598468564 |
BPTF
|
Health Risk |
Pathogenic |
— |
| RS1598473225 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1598473310 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1598477502 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS1598479779 |
PIEZO2
|
Health Risk |
Pathogenic |
Marden-Walker syndrome, Arthrogryposis |
| RS1598480419 |
TSEN54
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 2A, Pontocerebellar hypoplasia type 2A |
| RS1598482405 |
PIEZO2
|
Health Risk |
Pathogenic |
Arthrogryposis, distal |
| RS1598484479 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1598484851 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1598504016 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1598510954 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1598515363 |
FDXR
|
Health Risk |
Likely pathogenic |
Multiple mitochondrial dysfunctions syndrome 9b, Multiple mitochondrial dysfunctions syndrome 9b |
| RS1598518754 |
FDXR
|
Health Risk |
Likely pathogenic |
Auditory neuropathy-optic atrophy syndrome, Auditory neuropathy-optic atrophy syndrome |
| RS1598522408 |
LPIN2
|
Health Risk |
Likely pathogenic |
Majeed syndrome, Majeed syndrome |
| RS1598525781 |
DNAH17
|
Health Risk |
Pathogenic |
Spermatogenic failure 39, Spermatogenic failure 39 |
| RS1598534951 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1598535096 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1598540478 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1598548256 |
ACTG1
|
Health Risk |
Likely pathogenic |
Baraitser-winter syndrome 2, Baraitser-winter syndrome 2 |
| RS1598548614 |
ACTG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Baraitser-winter syndrome 2, ACTG1-related disorder |
| RS1598551290 |
ACTG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 20, Baraitser-winter syndrome 2 |
| RS1598560094 |
PSMD12
|
Health Risk |
Pathogenic |
— |
| RS1598563750 |
PSMD12
|
Health Risk |
Pathogenic |
— |
| RS1598572298 |
DSC2
|
Health Risk |
Pathogenic |
Arrhythmogenic right ventricular dysplasia 11, Cardiovascular phenotype |
| RS1598574154 |
PSMD12
|
Health Risk |
Pathogenic |
Stankiewicz-Isidor syndrome, Stankiewicz-Isidor syndrome |
| RS1598575231 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1598577666 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS1598578030 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1598580364 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1598580407 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1598581682 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1598581919 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS1598582021 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1598584825 |
USH1G
|
Health Risk |
Pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS1598585402 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1598588782 |
CACNA1G
|
Health Risk |
Likely pathogenic |
— |
| RS1598592533 |
DSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 11, Arrhythmogenic right ventricular dysplasia 11 |
| RS1598592604 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1598595659 |
DNAH17
|
Health Risk |
Pathogenic |
Spermatogenic failure 39, Spermatogenic failure 39 |
| RS1598598205 |
SCAPER
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder and retinitis pigmentosa, IDDRP |
| RS1598599641 |
BPTF
|
Health Risk |
Pathogenic |
— |
| RS1598604607 |
EIF4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1598620094 |
TLK2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 57 |
| RS1598632432 |
SCAPER
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder and retinitis pigmentosa, IDDRP |
| RS1598639584 |
CARD14
|
Health Risk |
Pathogenic |
Psoriasis 2, Pityriasis rubra pilaris |
| RS1598639617 |
CARD14
|
Health Risk |
Pathogenic |
Papulosquamous eruptions, Pityriasis rubra pilaris |
| RS1598639659 |
CARD14
|
Health Risk |
Pathogenic |
Papulosquamous eruptions, Papulosquamous eruptions |
| RS1598639974 |
CARD14
|
Health Risk |
Pathogenic |
Papulosquamous eruptions, Papulosquamous eruptions |
| RS1598676325 |
TLK2
|
Health Risk |
Pathogenic |
— |
| RS1598681680 |
BPTF
|
Health Risk |
Pathogenic |
— |
| RS1598690937 |
ITGB3
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia 2 |
| RS1598690979 |
ITGB3
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1598699465 |
DSG1
|
Health Risk |
Pathogenic |
— |
| RS1598700249 |
ITGB3
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia, Macrothrombocytopenia |
| RS1598702827 |
ITGB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Abnormal platelet aggregation, Thrombocytopenia |
| RS1598717056 |
PDE6G
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 57, Retinitis pigmentosa |
| RS1598734446 |
GATA6
|
Health Risk |
Pathogenic |
— |
| RS1598736884 |
SGSH
|
Health Risk |
Likely pathogenic |
— |
| RS1598737972 |
GATA6
|
Health Risk |
Pathogenic |
Persistent truncus arteriosus, Atrioventricular septal defect 5 |